Clinical Trial Update: Prophylaxis Vaccine Antibodies Ebola [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a prophylaxis vaccine antibodies targeting Ebola Virus Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: Ebola Virus Disease | Phase 2 | Status: UNKNOWN